Cancer research
Fresh data on Oncology - Small Bowel Cancer have been presented in a new report by researchers at the Mashhad University of Medical Sciences. The study, which examined the current evidence on targeted therapy and immunotherapy for Small Bowel Cancer (SBC), found that these treatments may have the potential to
Cancer research
Researchers at the University of Florence, Italy, have made significant advancements in the treatment of gastric cancer using fluorescence-guided surgery. According to the study, published in the journal Biomedicines, the team focused on developing a fluorescent molecule that can selectively target tumor tissues, enabling real-time detection of tumor nodules and
Cancer research
Research conducted by Kyung Hee University in Seoul, South Korea, has investigated the effectiveness of colistin therapy in cancer patients with multidrug-resistant Gram-negative bacterial (MDR GNB) infections. The study, published in Medicina, aimed to evaluate the mortality risk associated with colistin versus non-colistin regimens in cancer patients with MDR GNB
Cancer research
Research conducted by University of Campania Luigi Vanvitelli has found a significant link between metabolic dysfunction, type 2 diabetes mellitus (T2DM), and primary liver cancer (PLC). According to the study, individuals with T2DM and metabolic dysfunction-associated steatotic liver disease (MASLD) are at a higher risk of developing PLC. The researchers
Cancer research
New research conducted by a team of researchers at Prince Sattam bin Abdulaziz University has shed light on the prevalence of Helicobacter pylori infection among young adults in Saudi Arabia. According to the study, approximately 78% of participants aged 18-45 years were found to be infected with H. pylori, with
Cancer research
Research has revealed disturbing disparities in prostate cancer diagnosis and treatment among Black men in Louisiana, with a new study shedding light on the potential role of environmental factors in exacerbating these differences. According to recent findings published in the journal Current Oncology, environmental risk factors, including air toxicity, acetaldehyde
Cancer research
A new study has shown promise for a novel treatment approach using combination immunotherapy before and after surgery for patients with operable mesothelioma, a rare and aggressive cancer typically caused by asbestos exposure. The study, led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute
Cancer research
Researchers at the University of Texas MD Anderson Cancer Center have found that the combination of pembrolizumab and lenvatinib demonstrates favorable clinical benefit in recurrent, platinum resistant microsatellite stable (MSS)/mismatch repair proficient (pMMR) ovarian cancer. This study adds to the growing body of evidence supporting the use of immunotherapy
Cancer research
A Phase 3 clinical trial has been initiated by the University of Birmingham to investigate the efficacy of apixaban in preventing blood clots in lung cancer patients undergoing systemic anticancer treatment. The trial aims to enroll a sample of 1456 participants from the USA and will be led by principal
Cancer research
Researchers from Shanghai Jiao Tong University School of Medicine in Shanghai, People's Republic of China, have identified a new potential treatment for colon cancer through the repurposing of an existing FDA-approved drug. The study, published in Pharmaceuticals, found that menadione, a small molecular compound, can induce programmed cell
Cancer research
Researchers at the University of Chinese Medicine have made a significant discovery in the fight against colon cancer, identifying a potential biomarker for early detection. The study, published in Discover Oncology, found that the B9D2 gene, essential for ciliary function, is significantly upregulated in colon cancer patients, making it a
Cancer research
Researchers at the University of Michigan Rogel Cancer Center are nearing the recruitment phase for a Phase 2 clinical trial examining the effects of ovarian function suppression for breast cancer patients. The trial, led by principal investigator Norah L. Henry, aims to compare the efficacy of leuprolide at different doses
